A grant from the Rosenau Family Research Foundation will examine how an enzyme deficiency in the brain leads to this fatal ...

BUFFALO, N.Y. – A University at Buffalo researcher working on Krabbe disease (KD) has been awarded a $250,000 grant from the Rosenau Family Research Foundation to investigate how an enzyme deficiency ...

Legendary Bills QB Jim Kelly takes a timeout to talk about his Hall of Fame career and Sunday’s AFC Championship between his ...

Passage Bio (PASG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from ...

Passage Bio, Inc., disclosed in an 8-K filing on January 8, 2025, that it has initiated a restructuring plan aimed at ceasing lab operations at its leased laboratory space in Hopewell, New Jersey, ...

Alzhiemer’s Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is headquartered in Bethesda, Maryland.

The Brazilian project will focus on six programmes, targeting GM1 gangliosidosis (GM1), Krabbe disease, metachromatic leukodystrophy (MLD), and three unnamed programmes. The funding will be used ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...